A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases

Abstract Congenital heart disease is the leading cause of death in the first year of life. Mutations only in few genes have been linked to some cases of CHD. Thalidomide was used by pregnant women for morning sickness but was removed from the market because it caused severe malformations including C...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Athar Khalil, Rachel Tanos, Nehmé El-Hachem, Mazen Kurban, Patrice Bouvagnet, Fadi Bitar, Georges Nemer
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/159fba6c65b64a8ab565eb39390cea36
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:159fba6c65b64a8ab565eb39390cea36
record_format dspace
spelling oai:doaj.org-article:159fba6c65b64a8ab565eb39390cea362021-12-02T11:53:00ZA HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases10.1038/s41598-017-01641-32045-2322https://doaj.org/article/159fba6c65b64a8ab565eb39390cea362017-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-01641-3https://doaj.org/toc/2045-2322Abstract Congenital heart disease is the leading cause of death in the first year of life. Mutations only in few genes have been linked to some cases of CHD. Thalidomide was used by pregnant women for morning sickness but was removed from the market because it caused severe malformations including CHDs. We used both in silico docking software, and in vitro molecular and biochemical methods to document a novel interaction involving Thalidomide, TBX5, and HAND2. Thalidomide binds readily to TBX5 through amino acids R81, R82, and K226 all implicated in DNA binding. It reduces TBX5 binding to DNA by 40%, and suppresses TBX5 mediated activation of the NPPA and VEGF promoters by 70%. We documented a novel interaction between TBX5 and HAND2, and showed that a p.G202V HAND2 variant associated with CHD and coronary artery diseases found in a large Lebanese family with high consanguinity, drastically inhibited this interaction by 90%. Similarly, thalidomide inhibited the TBX5/HAND2 physical interaction, and the in silico docking revealed that the same amino acids involved in the interaction of TBX5 with DNA are also involved in its binding to HAND2. Our results establish a HAND2/TBX5 pathway implicated in heart development and diseases.Athar KhalilRachel TanosNehmé El-HachemMazen KurbanPatrice BouvagnetFadi BitarGeorges NemerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Athar Khalil
Rachel Tanos
Nehmé El-Hachem
Mazen Kurban
Patrice Bouvagnet
Fadi Bitar
Georges Nemer
A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases
description Abstract Congenital heart disease is the leading cause of death in the first year of life. Mutations only in few genes have been linked to some cases of CHD. Thalidomide was used by pregnant women for morning sickness but was removed from the market because it caused severe malformations including CHDs. We used both in silico docking software, and in vitro molecular and biochemical methods to document a novel interaction involving Thalidomide, TBX5, and HAND2. Thalidomide binds readily to TBX5 through amino acids R81, R82, and K226 all implicated in DNA binding. It reduces TBX5 binding to DNA by 40%, and suppresses TBX5 mediated activation of the NPPA and VEGF promoters by 70%. We documented a novel interaction between TBX5 and HAND2, and showed that a p.G202V HAND2 variant associated with CHD and coronary artery diseases found in a large Lebanese family with high consanguinity, drastically inhibited this interaction by 90%. Similarly, thalidomide inhibited the TBX5/HAND2 physical interaction, and the in silico docking revealed that the same amino acids involved in the interaction of TBX5 with DNA are also involved in its binding to HAND2. Our results establish a HAND2/TBX5 pathway implicated in heart development and diseases.
format article
author Athar Khalil
Rachel Tanos
Nehmé El-Hachem
Mazen Kurban
Patrice Bouvagnet
Fadi Bitar
Georges Nemer
author_facet Athar Khalil
Rachel Tanos
Nehmé El-Hachem
Mazen Kurban
Patrice Bouvagnet
Fadi Bitar
Georges Nemer
author_sort Athar Khalil
title A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases
title_short A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases
title_full A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases
title_fullStr A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases
title_full_unstemmed A HAND to TBX5 Explains the Link Between Thalidomide and Cardiac Diseases
title_sort hand to tbx5 explains the link between thalidomide and cardiac diseases
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/159fba6c65b64a8ab565eb39390cea36
work_keys_str_mv AT atharkhalil ahandtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT racheltanos ahandtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT nehmeelhachem ahandtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT mazenkurban ahandtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT patricebouvagnet ahandtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT fadibitar ahandtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT georgesnemer ahandtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT atharkhalil handtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT racheltanos handtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT nehmeelhachem handtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT mazenkurban handtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT patricebouvagnet handtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT fadibitar handtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
AT georgesnemer handtotbx5explainsthelinkbetweenthalidomideandcardiacdiseases
_version_ 1718394908815917056